VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 110 filers reported holding VOYAGER THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 1.85 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $380 | -99.2% | 50,000 | +426.3% | 0.00% | – |
| Q1 2021 | $45,000 | -32.8% | 9,500 | 0.0% | 0.00% | – |
| Q4 2020 | $67,000 | -35.6% | 9,500 | 0.0% | 0.00% | – |
| Q3 2020 | $104,000 | -80.0% | 9,500 | -52.0% | 0.00% | -100.0% |
| Q2 2019 | $521,000 | +101.2% | 19,800 | +63.6% | 0.00% | +50.0% |
| Q1 2019 | $259,000 | +191.0% | 12,100 | +22.2% | 0.00% | +100.0% |
| Q4 2018 | $89,000 | -65.6% | 9,900 | -18.2% | 0.00% | -50.0% |
| Q3 2018 | $259,000 | +2.8% | 12,100 | -2.4% | 0.00% | 0.0% |
| Q2 2018 | $252,000 | +11.0% | 12,400 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $227,000 | – | 12,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $60,077,000 | 50.34% |
| ARMISTICE CAPITAL, LLC | 2,836,000 | $26,658,000 | 2.02% |
| Casdin Capital, LLC | 1,128,075 | $10,604,000 | 1.81% |
| BB BIOTECH AG | 2,865,841 | $26,939,000 | 0.86% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,284,697 | $12,076,000 | 0.81% |
| Aevitas Wealth Management, Inc. | 48,300 | $454,000 | 0.46% |
| GREAT POINT PARTNERS LLC | 365,132 | $3,432,000 | 0.43% |
| Patriot Financial Group Insurance Agency, LLC | 61,320 | $576,000 | 0.38% |
| HARBOURVEST PARTNERS LLC | 72,726 | $684,000 | 0.32% |
| Birchview Capital, LP | 33,000 | $310,000 | 0.29% |